+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Point of Care Diagnostics Market By Product, By Mode Of Prescription, By End User: Global Opportunity Analysis and Industry Forecast, 2020-2030

  • PDF Icon

    Report

  • 215 Pages
  • March 2022
  • Region: Global
  • Allied Market Research
  • ID: 5640368
UP TO OFF until Nov 15th 2024
The point-of-care (POC) tests refer to the diagnostic procedures, which are conducted outside laboratories. POC diagnostic procedures are carried out by various POC diagnostic devices, which are used to test cholesterol and glucose levels, enzyme analysis, drug abuse testing, diagnosis of infectious diseases, and pregnancy testing. In addition, cardiac markers, fecal occult blood tests, and blood gases tests can also be performed using POC diagnostic devices.

An increase in the prevalence of various infectious diseases and several initiatives implemented by government and non-government associations for rising health awareness are major factors that drive the global point-of-care diagnostic market. In addition, technological advancements in POC diagnostic devices and introduction of home-based POC devices; and an increase in healthcare spending support the growth of the market. However, stringent government regulations for the approval of POC diagnostic devices and reimbursement issues for the POC devices are some of the major restraints that obstruct the growth of the market. Furthermore, developing countries, such as China and India provide huge growth opportunities to the global point-of-care diagnostics market.

The global point-of-care diagnostic market is segmented on the basis of product, end-user, mode of prescription, and region.

By product, the point-of-care diagnostic kit market is segmented into glucose monitoring kit, infectious diseases testing kit, pregnancy, and fertility testing kit, hematology testing kit, cardiometabolic monitoring kit, urinalysis testing kit, cholesterol test strips, drug of abuse testing kit, and others. Among these, the glucose monitoring kits segment dominates the global point-of-care diagnostics market owing to the increase in the prevalence of diabetes globally. However, the infectious disease testing kit is the fastest-growing segment during the forecast period. This is due to the rise in awareness about the various infectious diseases, rapid product launches, and initiatives implemented by government organizations for free check-ups in public places.

By end-user, the global point-of-care diagnostics market is segmented into professional diagnostic centers, research laboratories, homes, and others, Among these end users, the professional diagnostic centers dominate the global point-of-care diagnostics market.

By mode of prescription, the global point-of-care diagnostics market is segmented into prescription-based point-of-care diagnostics and over-the-counter (OTC)-based point-of-care diagnostics market. The prescription-based point-of-care diagnostics are most frequently used in healthcare facilities and prescribed by healthcare professionals.

Geographically, the market is segmented across four major regions, such as North America, Europe, Asia-Pacific, and LAMEA. North America accounted for the largest market share in the point-of-care diagnostic market. Asia-Pacific region is expected to emerge as the region with maximum growth potential due to the growth in the focus of key players in emerging economies and improvement in healthcare infrastructure in the region.

The report provides extensive competitive analysis and profiles of key market players operating in the point-of-care diagnostic market, such as Abbott Laboratories, Siemens AG, Hoffmann-La Roche Ltd, SINOCARE INC., Johnson & Johnson, Sysmex Corporation, NOVA Biomedical, Danaher Corporation, Becton Dickinson, and Company, and Bio-Rad laboratories.

Key Benefits For Stakeholders


  • The report provides an in-depth analysis of the global point-of-care diagnostic Kit market size along with the current trends and future estimations to elucidate the imminent investment pockets.
  • It offers market analysis from 2021 to 2030, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.
  • A comprehensive analysis of the region assists to understand the regional market and facilitate strategic business planning and determine prevailing opportunities.
  • The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global Point of Care Diagnostic Kit market.

Key Market Segments


BY PRODUCT

  • Glucose Monitoring Kits
  • Infectious Diseases Testing Kits
  • Pregnancy And Fertility Testing Kits
  • Hematology Testing Kits
  • Cardiometabolic Monitoring Kits
  • Urinalysis Testing Kits
  • Cholesterol Test Strips
  • Others
  • Drugs Abuse Testing Kits

BY MODE OF PRESCRIPTION

  • Prescription Based Devices
  • Otc Based Devices

BY END USER

  • Professional Diagnostic Centers
  • Research Laboratories
  • Home Care
  • Others

BY REGION

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Rest Of Asia Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

Key Market Players

  • Johnson and Johnson
  • sysmex corporation
  • Nova Biomedical
  • Danaher Corporation
  • Becton Dickinson and Company
  • bioMrieux SA
  • Abbott Laboratories
  • Siemens AG
  • Hoffmann La Roche Ltd
  • Sinocare Inc.

 

Please note:

  • Online Access price format is valid for 60 days access. Printing is not enabled.
  • PDF Single and Enterprise price formats enable printing.

 

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Porter’s five forces analysis
3.4. Top player positioning
3.5. Market dynamics
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
3.6. COVID-19 Impact Analysis on the market
CHAPTER 4: POINT OF CARE DIAGNOSTICS MARKET, BY PRODUCT
4.1 Overview
4.1.1 Market size and forecast
4.2 Glucose Monitoring Kits
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Infectious Diseases Testing Kits
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
4.4 Pregnancy And Fertility Testing Kits
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market analysis by country
4.5 Hematology Testing Kits
4.5.1 Key market trends, growth factors and opportunities
4.5.2 Market size and forecast, by region
4.5.3 Market analysis by country
4.6 Cardiometabolic Monitoring Kits
4.6.1 Key market trends, growth factors and opportunities
4.6.2 Market size and forecast, by region
4.6.3 Market analysis by country
4.7 Urinalysis Testing Kits
4.7.1 Key market trends, growth factors and opportunities
4.7.2 Market size and forecast, by region
4.7.3 Market analysis by country
4.8 Cholesterol Test Strips
4.8.1 Key market trends, growth factors and opportunities
4.8.2 Market size and forecast, by region
4.8.3 Market analysis by country
4.9 Drugs Abuse Testing Kits
4.9.1 Key market trends, growth factors and opportunities
4.9.2 Market size and forecast, by region
4.9.3 Market analysis by country
5.0 Others
5.0.1 Key market trends, growth factors and opportunities
5.0.2 Market size and forecast, by region
5.0.3 Market analysis by country
CHAPTER 5: POINT OF CARE DIAGNOSTICS MARKET, BY MODE OF PRESCRIPTION
5.1 Overview
5.1.1 Market size and forecast
5.2 Prescription Based Devices
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Otc Based Devices
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
CHAPTER 6: POINT OF CARE DIAGNOSTICS MARKET, BY END USER
6.1 Overview
6.1.1 Market size and forecast
6.2 Professional Diagnostic Centers
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.3 Research Laboratories
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
6.4 Home Care
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market analysis by country
6.5 Others
6.5.1 Key market trends, growth factors and opportunities
6.5.2 Market size and forecast, by region
6.5.3 Market analysis by country
CHAPTER 7: POINT OF CARE DIAGNOSTICS MARKET, BY REGION
7.1 Overview
7.1.1 Market size and forecast
7.2 North America
7.2.1 Key trends and opportunities
7.2.2 North America Market size and forecast, by Product
7.2.3 North America Market size and forecast, by Mode Of Prescription
7.2.4 North America Market size and forecast, by End User
7.2.5 North America Market size and forecast, by country
7.2.5.1 U.S.
7.2.5.1.1 Market size and forecast, by Product
7.2.5.1.2 Market size and forecast, by Mode Of Prescription
7.2.5.1.3 Market size and forecast, by End User
7.2.5.2 Canada
7.2.5.2.1 Market size and forecast, by Product
7.2.5.2.2 Market size and forecast, by Mode Of Prescription
7.2.5.2.3 Market size and forecast, by End User
7.2.5.3 Mexico
7.2.5.3.1 Market size and forecast, by Product
7.2.5.3.2 Market size and forecast, by Mode Of Prescription
7.2.5.3.3 Market size and forecast, by End User
7.3 Europe
7.3.1 Key trends and opportunities
7.3.2 Europe Market size and forecast, by Product
7.3.3 Europe Market size and forecast, by Mode Of Prescription
7.3.4 Europe Market size and forecast, by End User
7.3.5 Europe Market size and forecast, by country
7.3.5.1 Germany
7.3.5.1.1 Market size and forecast, by Product
7.3.5.1.2 Market size and forecast, by Mode Of Prescription
7.3.5.1.3 Market size and forecast, by End User
7.3.5.2 France
7.3.5.2.1 Market size and forecast, by Product
7.3.5.2.2 Market size and forecast, by Mode Of Prescription
7.3.5.2.3 Market size and forecast, by End User
7.3.5.3 U.K.
7.3.5.3.1 Market size and forecast, by Product
7.3.5.3.2 Market size and forecast, by Mode Of Prescription
7.3.5.3.3 Market size and forecast, by End User
7.3.5.4 Italy
7.3.5.4.1 Market size and forecast, by Product
7.3.5.4.2 Market size and forecast, by Mode Of Prescription
7.3.5.4.3 Market size and forecast, by End User
7.3.5.5 Spain
7.3.5.5.1 Market size and forecast, by Product
7.3.5.5.2 Market size and forecast, by Mode Of Prescription
7.3.5.5.3 Market size and forecast, by End User
7.3.5.6 Rest of Europe
7.3.5.6.1 Market size and forecast, by Product
7.3.5.6.2 Market size and forecast, by Mode Of Prescription
7.3.5.6.3 Market size and forecast, by End User
7.4 Asia-Pacific
7.4.1 Key trends and opportunities
7.4.2 Asia-Pacific Market size and forecast, by Product
7.4.3 Asia-Pacific Market size and forecast, by Mode Of Prescription
7.4.4 Asia-Pacific Market size and forecast, by End User
7.4.5 Asia-Pacific Market size and forecast, by country
7.4.5.1 Japan
7.4.5.1.1 Market size and forecast, by Product
7.4.5.1.2 Market size and forecast, by Mode Of Prescription
7.4.5.1.3 Market size and forecast, by End User
7.4.5.2 China
7.4.5.2.1 Market size and forecast, by Product
7.4.5.2.2 Market size and forecast, by Mode Of Prescription
7.4.5.2.3 Market size and forecast, by End User
7.4.5.3 Australia
7.4.5.3.1 Market size and forecast, by Product
7.4.5.3.2 Market size and forecast, by Mode Of Prescription
7.4.5.3.3 Market size and forecast, by End User
7.4.5.4 India
7.4.5.4.1 Market size and forecast, by Product
7.4.5.4.2 Market size and forecast, by Mode Of Prescription
7.4.5.4.3 Market size and forecast, by End User
7.4.5.5 South Korea
7.4.5.5.1 Market size and forecast, by Product
7.4.5.5.2 Market size and forecast, by Mode Of Prescription
7.4.5.5.3 Market size and forecast, by End User
7.4.5.6 Rest Of Asia Pacific
7.4.5.6.1 Market size and forecast, by Product
7.4.5.6.2 Market size and forecast, by Mode Of Prescription
7.4.5.6.3 Market size and forecast, by End User
7.5 LAMEA
7.5.1 Key trends and opportunities
7.5.2 LAMEA Market size and forecast, by Product
7.5.3 LAMEA Market size and forecast, by Mode Of Prescription
7.5.4 LAMEA Market size and forecast, by End User
7.5.5 LAMEA Market size and forecast, by country
7.5.5.1 Brazil
7.5.5.1.1 Market size and forecast, by Product
7.5.5.1.2 Market size and forecast, by Mode Of Prescription
7.5.5.1.3 Market size and forecast, by End User
7.5.5.2 Saudi Arabia
7.5.5.2.1 Market size and forecast, by Product
7.5.5.2.2 Market size and forecast, by Mode Of Prescription
7.5.5.2.3 Market size and forecast, by End User
7.5.5.3 South Africa
7.5.5.3.1 Market size and forecast, by Product
7.5.5.3.2 Market size and forecast, by Mode Of Prescription
7.5.5.3.3 Market size and forecast, by End User
7.5.5.4 Rest of LAMEA
7.5.5.4.1 Market size and forecast, by Product
7.5.5.4.2 Market size and forecast, by Mode Of Prescription
7.5.5.4.3 Market size and forecast, by End User
CHAPTER 8: COMPANY LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments
CHAPTER 9: COMPANY PROFILES
9.1 Johnson and Johnson
9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Operating business segments
9.1.4 Product portfolio
9.1.5 Business performance
9.1.6 Key strategic moves and developments
9.2 sysmex corporation
9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Operating business segments
9.2.4 Product portfolio
9.2.5 Business performance
9.2.6 Key strategic moves and developments
9.3 Nova Biomedical
9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Operating business segments
9.3.4 Product portfolio
9.3.5 Business performance
9.3.6 Key strategic moves and developments
9.4 Danaher Corporation
9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Operating business segments
9.4.4 Product portfolio
9.4.5 Business performance
9.4.6 Key strategic moves and developments
9.5 Becton Dickinson and Company
9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Operating business segments
9.5.4 Product portfolio
9.5.5 Business performance
9.5.6 Key strategic moves and developments
9.6 bioMrieux SA
9.6.1 Company overview
9.6.2 Company snapshot
9.6.3 Operating business segments
9.6.4 Product portfolio
9.6.5 Business performance
9.6.6 Key strategic moves and developments
9.7 Abbott Laboratories
9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Operating business segments
9.7.4 Product portfolio
9.7.5 Business performance
9.7.6 Key strategic moves and developments
9.8 Siemens AG
9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Operating business segments
9.8.4 Product portfolio
9.8.5 Business performance
9.8.6 Key strategic moves and developments
9.9 Hoffmann La Roche Ltd
9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Operating business segments
9.9.4 Product portfolio
9.9.5 Business performance
9.9.6 Key strategic moves and developments
9.10 Sinocare Inc.
9.10.1 Company overview
9.10.2 Company snapshot
9.10.3 Operating business segments
9.10.4 Product portfolio
9.10.5 Business performance
9.10.6 Key strategic moves and developments
LIST OF TABLES
Table 1. Global Point of Care Diagnostics Market, by Product, 2020-2030, ($Million)
Table 2. Point of Care Diagnostics Market Revenue, for Glucose Monitoring Kits, by Region, 2020-2030, ($Million)
Table 3. Point of Care Diagnostics Market Glucose Monitoring Kits by Country, 2020-2030, ($Million)
Table 4. Point of Care Diagnostics Market Revenue, for Infectious Diseases Testing Kits, by Region, 2020-2030, ($Million)
Table 5. Point of Care Diagnostics Market Infectious Diseases Testing Kits by Country, 2020-2030, ($Million)
Table 6. Point of Care Diagnostics Market Revenue, for Pregnancy and Fertility Testing Kits, by Region, 2020-2030, ($Million)
Table 7. Point of Care Diagnostics Market Pregnancy and Fertility Testing Kits by Country, 2020-2030, ($Million)
Table 8. Point of Care Diagnostics Market Revenue, for Hematology Testing Kits, by Region, 2020-2030, ($Million)
Table 9. Point of Care Diagnostics Market Hematology Testing Kits by Country, 2020-2030, ($Million)
Table 10. Point of Care Diagnostics Market Revenue, for Cardiometabolic Monitoring Kits, by Region, 2020-2030, ($Million)
Table 11. Point of Care Diagnostics Market Cardiometabolic Monitoring Kits by Country, 2020-2030, ($Million)
Table 12. Point of Care Diagnostics Market Revenue, for Urinalysis Testing Kits, by Region, 2020-2030, ($Million)
Table 13. Point of Care Diagnostics Market Urinalysis Testing Kits by Country, 2020-2030, ($Million)
Table 14. Point of Care Diagnostics Market Revenue, for Cholesterol Test Strips, by Region, 2020-2030, ($Million)
Table 15. Point of Care Diagnostics Market Cholesterol Test Strips by Country, 2020-2030, ($Million)
Table 16. Point of Care Diagnostics Market Revenue, for Drugs Abuse Testing Kits, by Region, 2020-2030, ($Million)
Table 17. Point of Care Diagnostics Market Drugs Abuse Testing Kits by Country, 2020-2030, ($Million)
Table 18. Point of Care Diagnostics Market Revenue, for Others, by Region, 2020-2030, ($Million)
Table 19. Point of Care Diagnostics Market Others by Country, 2020-2030, ($Million)
Table 20. Global Point of Care Diagnostics Market, by Mode of Prescription, 2020-2030, ($Million)
Table 21. Point of Care Diagnostics Market Revenue, for Prescription Based Devices, by Region, 2020-2030, ($Million)
Table 22. Point of Care Diagnostics Market Prescription Based Devices by Country, 2020-2030, ($Million)
Table 23. Point of Care Diagnostics Market Revenue, for OTC Based Devices, by Region, 2020-2030, ($Million)
Table 24. Point of Care Diagnostics Market OTC Based Devices by Country, 2020-2030, ($Million)
Table 25. Global Point of Care Diagnostics Market, by End-user, 2020-2030, ($Million)
Table 26. Point of Care Diagnostics Market Revenue, for Professional Diagnostic Centers, by Region, 2020-2030, ($Million)
Table 27. Point of Care Diagnostics Market Professional Diagnostic Centers by Country, 2020-2030, ($Million)
Table 28. Point of Care Diagnostics Market Revenue, for Research Laboratories, by Region, 2020-2030, ($Million)
Table 29. Point of Care Diagnostics Market Research Laboratories by Country, 2020-2030, ($Million)
Table 30. Point of Care Diagnostics Market Revenue, for Home Care, by Region, 2020-2030, ($Million)
Table 31. Point of Care Diagnostics Market Home Care by Country, 2020-2030, ($Million)
Table 32. Point of Care Diagnostics Market Revenue, for Others, by Region, 2020-2030, ($Million)
Table 33. Point of Care Diagnostics Market Others by Country, 2020-2030, ($Million)
Table 34. Point of Care Diagnostics Market, by Region, 2020-2030, ($Million)
Table 35. North America Point of Care Diagnostics Market, by Product, 2020-2030, ($Million)
Table 36. North America Point of Care Diagnostics Market, by Mode of Prescription, 2020-2030, ($Million)
Table 37. North America Point of Care Diagnostics Market, by End-user, 2020-2030, ($Million)
Table 38. North America Point of Care Diagnostics Market, by Country, 2020-2030, ($Million)
Table 39. U.S. Point of Care Diagnostics Market by Product 2020-2030, ($Million)
Table 40. U.S. Point of Care Diagnostics Market by Mode of Prescription 2020-2030, ($Million)
Table 41. U.S. Point of Care Diagnostics Market by End-user 2020-2030, ($Million)
Table 42. Canada Point of Care Diagnostics Market by Product 2020-2030, ($Million)
Table 43. Canada Point of Care Diagnostics Market by Mode of Prescription 2020-2030, ($Million)
Table 44. Canada Point of Care Diagnostics Market by End-user 2020-2030, ($Million)
Table 45. Mexico Point of Care Diagnostics Market by Product 2020-2030, ($Million)
Table 46. Mexico Point of Care Diagnostics Market by Mode of Prescription 2020-2030, ($Million)
Table 47. Mexico Point of Care Diagnostics Market by End-user 2020-2030, ($Million)
Table 48. Europe Point of Care Diagnostics Market, by Product, 2020-2030, ($Million)
Table 49. Europe Point of Care Diagnostics Market, by Mode of Prescription, 2020-2030, ($Million)
Table 50. Europe Point of Care Diagnostics Market, by End-user, 2020-2030, ($Million)
Table 51. Europe Point of Care Diagnostics Market, by Country, 2020-2030, ($Million)
Table 52. Germany Point of Care Diagnostics Market by Product 2020-2030, ($Million)
Table 53. Germany Point of Care Diagnostics Market by Mode of Prescription 2020-2030, ($Million)
Table 54. Germany Point of Care Diagnostics Market by End-user 2020-2030, ($Million)
Table 55. France Point of Care Diagnostics Market by Product 2020-2030, ($Million)
Table 56. France Point of Care Diagnostics Market by Mode of Prescription 2020-2030, ($Million)
Table 57. France Point of Care Diagnostics Market by End-user 2020-2030, ($Million)
Table 58. U.K. Point of Care Diagnostics Market by Product 2020-2030, ($Million)
Table 59. U.K. Point of Care Diagnostics Market by Mode of Prescription 2020-2030, ($Million)
Table 60. U.K. Point of Care Diagnostics Market by End-user 2020-2030, ($Million)
Table 61. Italy Point of Care Diagnostics Market by Product 2020-2030, ($Million)
Table 62. Italy Point of Care Diagnostics Market by Mode of Prescription 2020-2030, ($Million)
Table 63. Italy Point of Care Diagnostics Market by End-user 2020-2030, ($Million)
Table 64. Spain Point of Care Diagnostics Market by Product 2020-2030, ($Million)
Table 65. Spain Point of Care Diagnostics Market by Mode of Prescription 2020-2030, ($Million)
Table 66. Spain Point of Care Diagnostics Market by End-user 2020-2030, ($Million)
Table 67. Rest of Europe Point of Care Diagnostics Market by Product 2020-2030, ($Million)
Table 68. Rest of Europe Point of Care Diagnostics Market by Mode of Prescription 2020-2030, ($Million)
Table 69. Rest of Europe Point of Care Diagnostics Market by End-user 2020-2030, ($Million)
Table 70. Asia-Pacific Point of Care Diagnostics Market, by Product, 2020-2030, ($Million)
Table 71. Asia-Pacific Point of Care Diagnostics Market, by Mode of Prescription, 2020-2030, ($Million)
Table 72. Asia-Pacific Point of Care Diagnostics Market, by End-user, 2020-2030, ($Million)
Table 73. Asia-Pacific Point of Care Diagnostics Market, by Country, 2020-2030, ($Million)
Table 74. Japan Point of Care Diagnostics Market by Product 2020-2030, ($Million)
Table 75. Japan Point of Care Diagnostics Market by Mode of Prescription 2020-2030, ($Million)
Table 76. Japan Point of Care Diagnostics Market by End-user 2020-2030, ($Million)
Table 77. China Point of Care Diagnostics Market by Product 2020-2030, ($Million)
Table 78. China Point of Care Diagnostics Market by Mode of Prescription 2020-2030, ($Million)
Table 79. China Point of Care Diagnostics Market by End-user 2020-2030, ($Million)
Table 80. Australia Point of Care Diagnostics Market by Product 2020-2030, ($Million)
Table 81. Australia Point of Care Diagnostics Market by Mode of Prescription 2020-2030, ($Million)
Table 82. Australia Point of Care Diagnostics Market by End-user 2020-2030, ($Million)
Table 83. India Point of Care Diagnostics Market by Product 2020-2030, ($Million)
Table 84. India Point of Care Diagnostics Market by Mode of Prescription 2020-2030, ($Million)
Table 85. India Point of Care Diagnostics Market by End-user 2020-2030, ($Million)
Table 86. South Korea Point of Care Diagnostics Market by Product 2020-2030, ($Million)
Table 87. South Korea Point of Care Diagnostics Market by Mode of Prescription 2020-2030, ($Million)
Table 88. South Korea Point of Care Diagnostics Market by End-user 2020-2030, ($Million)
Table 89. Rest of Asia-Pacific Point of Care Diagnostics Market by Product 2020-2030, ($Million)
Table 90. Rest of Asia-Pacific Point of Care Diagnostics Market by Mode of Prescription 2020-2030, ($Million)
Table 91. Rest of Asia-Pacific Point of Care Diagnostics Market by End-user 2020-2030, ($Million)
Table 92. LAMEA Point of Care Diagnostics Market, by Product, 2020-2030, ($Million)
Table 93. LAMEA Point of Care Diagnostics Market, by Mode of Prescription, 2020-2030, ($Million)
Table 94. LAMEA Point of Care Diagnostics Market, by End-user, 2020-2030, ($Million)
Table 95. LAMEA Point of Care Diagnostics Market, by Country, 2020-2030, ($Million)
Table 96. Brazil Point of Care Diagnostics Market by Product 2020-2030, ($Million)
Table 97. Brazil Point of Care Diagnostics Market by Mode of Prescription 2020-2030, ($Million)
Table 98. Brazil Point of Care Diagnostics Market by End-user 2020-2030, ($Million)
Table 99. Saudi Arabia Point of Care Diagnostics Market by Product 2020-2030, ($Million)
Table 100. Saudi Arabia Point of Care Diagnostics Market by Mode of Prescription 2020-2030, ($Million)
Table 101. Saudi Arabia Point of Care Diagnostics Market by End-user 2020-2030, ($Million)
Table 102. South Africa Point of Care Diagnostics Market by Product 2020-2030, ($Million)
Table 103. South Africa Point of Care Diagnostics Market by Mode of Prescription 2020-2030, ($Million)
Table 104. South Africa Point of Care Diagnostics Market by End-user 2020-2030, ($Million)
Table 105. Rest of LAMEA Point of Care Diagnostics Market by Product 2020-2030, ($Million)
Table 106. Rest of LAMEA Point of Care Diagnostics Market by Mode of Prescription 2020-2030, ($Million)
Table 107. Rest of LAMEA Point of Care Diagnostics Market by End-user 2020-2030, ($Million)
Table 108. Johnson and Johnson: Company Snapshot
Table 109. Johnson and Johnson: Operating Segments
Table 110. Johnson and Johnson: Product Portfolio
Table 111. Johnson and Johnson: Net Sales
Table 112. Johnson and Johnson: Key Stratergies
Table 113. Sysmex Corporation: Company Snapshot
Table 114. Sysmex Corporation: Operating Segments
Table 115. Sysmex Corporation: Product Portfolio
Table 116. Sysmex Corporation: Net Sales
Table 117. Sysmex Corporation: Key Stratergies
Table 118. Nova Biomedical: Company Snapshot
Table 119. Nova Biomedical: Operating Segments
Table 120. Nova Biomedical: Product Portfolio
Table 121. Nova Biomedical: Net Sales
Table 122. Nova Biomedical: Key Stratergies
Table 123. Danaher Corporation: Company Snapshot
Table 124. Danaher Corporation: Operating Segments
Table 125. Danaher Corporation: Product Portfolio
Table 126. Danaher Corporation: Net Sales
Table 127. Danaher Corporation: Key Stratergies
Table 128. Becton Dickinson and Company: Company Snapshot
Table 129. Becton Dickinson and Company: Operating Segments
Table 130. Becton Dickinson and Company: Product Portfolio
Table 131. Becton Dickinson and Company: Net Sales
Table 132. Becton Dickinson and Company: Key Stratergies
Table 133. Biomrieux Sa: Company Snapshot
Table 134. Biomrieux Sa: Operating Segments
Table 135. Biomrieux Sa: Product Portfolio
Table 136. Biomrieux Sa: Net Sales
Table 137. Biomrieux Sa: Key Stratergies
Table 138. Abbott Laboratories: Company Snapshot
Table 139. Abbott Laboratories: Operating Segments
Table 140. Abbott Laboratories: Product Portfolio
Table 141. Abbott Laboratories: Net Sales
Table 142. Abbott Laboratories: Key Stratergies
Table 143. Siemens Ag: Company Snapshot
Table 144. Siemens Ag: Operating Segments
Table 145. Siemens Ag: Product Portfolio
Table 146. Siemens Ag: Net Sales
Table 147. Siemens Ag: Key Stratergies
Table 148. Hoffmann La Roche Ltd: Company Snapshot
Table 149. Hoffmann La Roche Ltd: Operating Segments
Table 150. Hoffmann La Roche Ltd: Product Portfolio
Table 151. Hoffmann La Roche Ltd: Net Sales
Table 152. Hoffmann La Roche Ltd: Key Stratergies
Table 153. Sinocare Inc.: Company Snapshot
Table 154. Sinocare Inc.: Operating Segments
Table 155. Sinocare Inc.: Product Portfolio
Table 156. Sinocare Inc.: Net Sales
Table 157. Sinocare Inc.: Key Stratergies
LIST OF FIGURES
Figure 1. Point of Care Diagnostics Market Segmentation
Figure 2. Point of Care Diagnostics Market, 2020-2030
Figure 3. Point of Care Diagnostics Market, 2020-2030
Figure 4. Top Investment Pockets, by Region
Figure 5. Porter Five-1
Figure 6. Porter Five-2
Figure 7. Porter Five-3
Figure 8. Porter Five-4
Figure 9. Porter Five-5
Figure 10. Top Player Positioning
Figure 11. Point of Care Diagnostics Market:Drivers, Restraints and Opportunities
Figure 11. Point of Care Diagnostics Market, by Product, 2020 (%)
Figure 12. Comparative Share Analysis of Glucose Monitoring Kits Point of Care Diagnostics Market, 2020-2030 (%)
Figure 13. Comparative Share Analysis of Infectious Diseases Testing Kits Point of Care Diagnostics Market, 2020-2030 (%)
Figure 14. Comparative Share Analysis of Pregnancy and Fertility Testing Kits Point of Care Diagnostics Market, 2020-2030 (%)
Figure 15. Comparative Share Analysis of Hematology Testing Kits Point of Care Diagnostics Market, 2020-2030 (%)
Figure 16. Comparative Share Analysis of Cardiometabolic Monitoring Kits Point of Care Diagnostics Market, 2020-2030 (%)
Figure 17. Comparative Share Analysis of Urinalysis Testing Kits Point of Care Diagnostics Market, 2020-2030 (%)
Figure 18. Comparative Share Analysis of Cholesterol Test Strips Point of Care Diagnostics Market, 2020-2030 (%)
Figure 19. Comparative Share Analysis of Drugs Abuse Testing Kits Point of Care Diagnostics Market, 2020-2030 (%)
Figure 20. Comparative Share Analysis of Others Point of Care Diagnostics Market, 2020-2030 (%)
Figure 21. Point of Care Diagnostics Market, by Mode of Prescription, 2020 (%)
Figure 22. Comparative Share Analysis of Prescription Based Devices Point of Care Diagnostics Market, 2020-2030 (%)
Figure 23. Comparative Share Analysis of OTC Based Devices Point of Care Diagnostics Market, 2020-2030 (%)
Figure 24. Point of Care Diagnostics Market, by End-user, 2020 (%)
Figure 25. Comparative Share Analysis of Professional Diagnostic Centers Point of Care Diagnostics Market, 2020-2030 (%)
Figure 26. Comparative Share Analysis of Research Laboratories Point of Care Diagnostics Market, 2020-2030 (%)
Figure 27. Comparative Share Analysis of Home Care Point of Care Diagnostics Market, 2020-2030 (%)
Figure 28. Comparative Share Analysis of Others Point of Care Diagnostics Market, 2020-2030 (%)
Figure 29. Point of Care Diagnostics Market by Region, 2020
Figure 30. U.S. Point of Care Diagnostics Market, 2020-2030 ($Million)
Figure 31. Canada Point of Care Diagnostics Market, 2020-2030 ($Million)
Figure 32. Mexico Point of Care Diagnostics Market, 2020-2030 ($Million)
Figure 33. Germany Point of Care Diagnostics Market, 2020-2030 ($Million)
Figure 34. France Point of Care Diagnostics Market, 2020-2030 ($Million)
Figure 35. U.K. Point of Care Diagnostics Market, 2020-2030 ($Million)
Figure 36. Italy Point of Care Diagnostics Market, 2020-2030 ($Million)
Figure 37. Spain Point of Care Diagnostics Market, 2020-2030 ($Million)
Figure 38. Rest of Europe Point of Care Diagnostics Market, 2020-2030 ($Million)
Figure 39. Japan Point of Care Diagnostics Market, 2020-2030 ($Million)
Figure 40. China Point of Care Diagnostics Market, 2020-2030 ($Million)
Figure 41. Australia Point of Care Diagnostics Market, 2020-2030 ($Million)
Figure 42. India Point of Care Diagnostics Market, 2020-2030 ($Million)
Figure 43. South Korea Point of Care Diagnostics Market, 2020-2030 ($Million)
Figure 44. Rest of Asia-Pacific Point of Care Diagnostics Market, 2020-2030 ($Million)
Figure 45. Brazil Point of Care Diagnostics Market, 2020-2030 ($Million)
Figure 46. Saudi Arabia Point of Care Diagnostics Market, 2020-2030 ($Million)
Figure 47. South Africa Point of Care Diagnostics Market, 2020-2030 ($Million)
Figure 48. Rest of LAMEA Point of Care Diagnostics Market, 2020-2030 ($Million)
Figure 49. Top Winning Strategies, by Year
Figure 50. Top Winning Strategies, by Development
Figure 51. Top Winning Strategies, by Company
Figure 52. Product Mapping of Top 10 Players
Figure 53. Competitive Dashboard
Figure 54. Competitive Heatmap of Top 10 Key Players
Figure 55. Johnson and Johnson.: Net Sales, ($Million)
Figure 56. Sysmex Corporation.: Net Sales, ($Million)
Figure 57. Nova Biomedical.: Net Sales, ($Million)
Figure 58. Danaher Corporation.: Net Sales, ($Million)
Figure 59. Becton Dickinson and Company.: Net Sales, ($Million)
Figure 60. Biomrieux SA.: Net Sales, ($Million)
Figure 61. Abbott Laboratories.: Net Sales, ($Million)
Figure 62. Siemens AG.: Net Sales, ($Million)
Figure 63. Hoffmann La Roche Ltd.: Net Sales, ($Million)
Figure 64. Sinocare Inc. Net Sales, ($Million)

Executive Summary

According to this report titled, 'POC Diagnostics Market Size,' the point of care diagnostics market size was valued at $29,478.63 million in 2020, and is estimated to reach $55.3 Billion by 2030, growing at a CAGR of 6.5% from 2021 to 2030.

Point-of-care (POC) diagnostic devices defined in this report are medical devices, which imply in the POC diagnostic procedures, used primarily in the investigation of various diseases, such as cancer, diabetes, cardiac diseases, and others. They allow healthcare professionals to diagnose and treat these medical conditions by analyzing the causes of diseases. The adoption of these devices increases among the professionals because they provide immediate direction for accurate treatment by offering instant diagnosis results. In addition, technological advancements in the POC diagnostic devices, such as the launch of innovative and advanced glucose monitoring kits and pregnancy and fertility kits have attracted end-users to adopt the devices for the testing and diagnosis procedures.

The major factors that boost the growth of the global Point of Care Diagnostics Market Growth include, an increase in the prevalence of various infectious diseases and several initiatives implemented by government and non-government associations for rising health awareness globally. The technological advancements in POC diagnostic devices and introduction of home-based POC devices and the increase in healthcare expenditure support the growth of the global point-of-care diagnostic market. In addition, developing countries, such as China and India provide huge growth opportunities to the global point of care diagnostic market. However, stringent government regulations for the approval of POC diagnostic devices and reimbursement issues for the POC devices restrict the growth of the POC Diagnostics Market.

The Point-of-care Diagnostics Market is segmented on the basis of product, end-user, mode of prescription, and region.

By product, the point-of-care diagnostic kit market is segmented into glucose monitoring kit, infectious diseases testing kit, pregnancy, and fertility testing kit, hematology testing kit, cardiometabolic monitoring kit, urinalysis testing kit, coagulation monitoring kit, tumor markers testing kit, cholesterol test strips, drug of abusee testing kit, fecal occult testing kit, and others. Glucose monitoring segments dominate the market owing to the rise in the diabetic patient population, especially in developing countries, and the growing demand for glucose testing.

On the basis of end-user, the global point-of-care diagnostic market is segmented into professional diagnostic centers, research laboratories, homes, and others, such as medical universities, not-for-profit organizations, and nursing homes. Among these end users, the professional diagnostic centers dominate in the global point-of-care diagnostic market due to the rise in frequency of chronic diseases requiring long-term care and regular monitoring in critical care units, as well as the fast-developing knowledge of the availability of cost-effective and highly creative POC diagnostic instruments.

By region, the Point of Care Diagnostics Industry is classified into North America, Europe, Asia Pacific, and LAMEA. North America garnered a major share of the point-of-care diagnostic market in 2020 and is expected to continue to dominate during the forecast period, owing to rise in cases of chronic diseases, such as diabetes and cancer, and a growing old age population is all expected to boost demand for point-of-care diagnostics in the region. However, Asia-Pacific is expected to register highest from 2021 to 2030.

Companies Mentioned

  • Johnson and Johnson
  • sysmex corporation
  • Nova Biomedical
  • Danaher Corporation
  • Becton Dickinson and Company
  • bioMrieux SA
  • Abbott Laboratories
  • Siemens AG
  • Hoffmann La Roche Ltd
  • Sinocare Inc.

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...